Triclabendazole
(Redirected from Egaten)
What is Triclabendazole?[edit | edit source]
Triclabendazole (EGATEN) is an anthelmintic used to treat fascioliasis in patients 6 years of age and older.
What are the uses of this medicine?[edit | edit source]
- This medicine is used to treat fascioliasis in patients 6 years of age and older.
- Fascioliasis is an infectious disease caused by the parasitic flatworms Fasciola hepatica and gigantica, also known as liver flukes.
- The initial infection is characterized by fever, abdominal pain, and increase elevation in liver enzymes.
- Over months to years, the disease may become chronic with occasional pain in the abdomen, jaundice, anemia, and blockage of bile ducts where adult flukes live.
- During this phase, parasite eggs are present in the stool.
How does this medicine work?[edit | edit source]
- Triclabendazole is an anthelmintic against Fasciola species.
- The mechanism by which triclabendazole exhibits its effect against Fasciola species is not fully elucidated.
- Studies in vitro and/or in infected animals suggest that triclabendazole and its active metabolites (sulfoxide and sulfone) are absorbed by the tegument of the immature and mature worms, leading to a decrease of the resting membrane potential, inhibition of tubulin function as well as protein and enzyme synthesis.
- These metabolic disturbances are associated with inhibition of motility, disruption of the surface as well as ultrastructure that includes inhibition of spermatogenesis and vitelline cells.
Who Should Not Use this medicine ?[edit | edit source]
This medicine cannot be used in patients with:
- known hypersensitivity to triclabendazole and/or to other benzimidazole derivatives or to any of the excipients in EGATEN.
What drug interactions can this medicine cause?[edit | edit source]
- No specific clinical drug interaction studies have been conducted for triclabendazole.
- However, in vitro data suggest the potential for increased plasma concentrations of CYP2C19 substrates with concomitant use of triclabendazole.
Is this medicine FDA approved?[edit | edit source]
- It was approved for use in the United States in 2019.
How should this medicine be used?[edit | edit source]
Recommended Dosage
- The recommended dose of EGATEN is 2 doses of 10 mg/kg given 12 hours apart in patients 6 years of age and older.
Administration
- The 250 mg tablets are functionally scored and divisible into two equal halves of 125 mg.
- If the dosage cannot be adjusted exactly, round the dose upwards.
- Take EGATEN orally with food.
- EGATEN tablets can be swallowed whole or divided in half and taken with water or crushed and administered with applesauce.
- The crushed tablet mixed with applesauce is stable for up to 4 hours.
What are the dosage forms and brand names of this medicine?[edit | edit source]
This medicine is available in fallowing doasage form:
- As Tablets: 250 mg, functionally scored
This medicine is available in fallowing brand namesː
- EGATEN
What side effects can this medication cause?[edit | edit source]
The most common side effects of this medicine include:
- abdominal pain
- hyperhidrosis
- nausea
- decreased appetite
- headache
- urticaria
- diarrhea
- vomiting
- musculoskeletal chest pain
- pruritus
What special precautions should I follow?[edit | edit source]
- This medicine may prolong QT interval.
- Monitor ECG in patients with a history of QT prolongation or who are taking medications which prolong the QT interval.
What to do in case of emergency/overdose?[edit | edit source]
The reported symptom of overdosage following ingestion of approximately 54 mg/kg of EGATEN (approximately 2.7 times the recommended dose) was nausea.
Management for overdosage
- Management can be done by osmotic diuresis.
Can this medicine be used in pregnancy?[edit | edit source]
- There are no available data on EGATEN use in pregnant women to inform a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes.
Can this medicine be used in children?[edit | edit source]
- Safety and effectiveness of EGATEN has been established in pediatric patients aged 6 years and older.
- Safety and effectiveness of EGATEN in pediatric patients below the age of 6 years have not been established.
What are the active and inactive ingredients in this medicine?[edit | edit source]
Active ingredient:
- TRICLABENDAZOLE
Inactive ingredients:
- LACTOSE MONOHYDRATE
- STARCH, CORN
- HYMETELLOSE
- MAGNESIUM STEARATE
- SILICON DIOXIDE
- FERRIC OXIDE RED
Who manufactures and distributes this medicine?[edit | edit source]
- Packager: Novartis Pharmaceuticals Corporation
What should I know about storage and disposal of this medication?[edit | edit source]
- Store in the original container.
- Store below 30°C (86°F).
Triclabendazole Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD